Inventor · disambiguated record
David G. Roe
Also filed as: ROE DAVID G · ROE DAVID GREGORY
21 granted patents·1 pending application·147 citations·filing 2003–2023
95Inventor score
Files withKARYOPHARM THERAPEUTICS INC8INFACARE PHARMACEUTICAL CORP6MEDICINOVA INC5MALLINCKRODT HOSPITAL PRODUCTS IP LTD2DRUMMOND GEORGE S1
Top patents by PatentIndex Score
22 records- 0198US11807629B2Polymorphs of SelinexorKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Nov 7, 2023·6 cites·7 claims
- 0298US11753401B2Polymorphs of SelinexorKARYOPHARM THERAPEUTICS INC·Filed 2023·Granted Sep 12, 2023·5 cites·23 claims
- 0398US11746102B2Polymorphs of selinexorKARYOPHARM THERAPEUTICS INC·Filed 2023·Granted Sep 5, 2023·5 cites·17 claims
- 0497US11078190B2Polymorphs of selinexorKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted Aug 3, 2021·11 cites·20 claims
- 0597US10519139B2Polymorphs of SelinexorKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Dec 31, 2019·17 cites·28 claims
- 0694US10662209B2High-purity large-scale preparation of stannsoporfinMALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2019·Granted May 26, 2020·4 cites·20 claims
- 0793US12371420B2Polymorphs of SelinexorKARYOPHARM THERAPEUTICS INC·Filed 2023·Granted Jul 29, 2025·1 cites·14 claims
- 0893US7960371B2High-purity large-scale preparation of stannsoporfinINFACARE PHARMACEUTICAL CORP·Filed 2007·Granted Jun 14, 2011·15 cites·31 claims
- 0992US11078220B2High-purity large-scale preparation of stannsoporfinMALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2020·Granted Aug 3, 2021·2 cites·20 claims
- 1091US8530458B2High-purity large-scale preparation of stannsoporfinDRUMMOND GEORGE S·Filed 2010·Granted Sep 10, 2013·16 cites·29 claims
- 1189US9107927B2High-purity large-scale preparation of stannsoporfinINFACARE PHARMACEUTICAL CORP·Filed 2014·Granted Aug 18, 2015·8 cites·20 claims
- 1289US7060854B2Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acidMEDICINOVA INC·Filed 2003·Granted Jun 13, 2006·17 cites·9 claims
- 1388US8835416B2High-purity large-scale preparation of stannsoporfinINFACARE PHARMACEUTICAL CORP·Filed 2013·Granted Sep 16, 2014·6 cites·20 claims
- 1488US7728169B2Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of useMEDICINOVA INC·Filed 2008·Granted Jun 1, 2010·9 cites·19 claims
- 1585US7064146B2Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of useMEDICINOVA INC·Filed 2003·Granted Jun 20, 2006·17 cites·12 claims
- 1684US7153993B2Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acidMEDICINOVA INC·Filed 2005·Granted Dec 26, 2006·4 cites·9 claims
- 1783US10273255B2High-purity large-scale preparation of stannsoporfinINFACARE PHARMACEUTICAL CORP·Filed 2018·Granted Apr 30, 2019·2 cites·3 claims
- 1883US9902745B2High-purity large-scale preparation of stannsoporfinINFACARE PHARMACEUTICAL CORP·Filed 2016·Granted Feb 27, 2018·2 cites·16 claims
- 1961US9517239B2High-purity large-scale preparation of stannsoporfinINFACARE PHARMACEUTICAL CORP·Filed 2015·Granted Dec 13, 2016·0 cites·16 claims
- 2058US7365224B2Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of useMEDICINOVA INC·Filed 2005·Granted Apr 29, 2008·0 cites·12 claims
- 2158US2024287041A1Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline formsKARYOPHARM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2254US12479806B2Process for preparing XPO1 inhibitors and intermediates for use in the preparation of XPO1 inhibitorsKARYOPHARM THERAPEUTICS INC·Filed 2020·Granted Nov 25, 2025·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when David G. Roe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →